Physician profile
John Edmond Wright
NPI 1326571670
$2,813.42
in general payments reported to CMS, 2019-2025
17 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $226 · 2021: $318 · 2022: $190 · 2023: $620 · 2024: $810 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,811 · Education: $53.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,810.85 |
| Education | $53.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $885.15 | 2019-2025 | Hydrus Microstent, Clareon |
| Abbvie INC. | $499.56 | 2022-2025 | Durysta, Xen Glaucoma Treatment System |
| Sight Sciences, INC. | $181.06 | 2022-2024 | Omni Surgical System |
| Mallinckrodt Hospital Products INC. | $146.73 | 2023 | Acthar |
| Harrow Eye, LLC | $136.86 | 2024-2025 | Tobradex St, Natacyn, Iheezo |
| Omeros Corporation | $124.99 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $123.18 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $120.06 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $103.07 | 2019 | |
| Rxsight INC | $98.70 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Allergan, INC. | $94.24 | 2019 | |
| Iridex Corporation | $75.92 | 2023 | |
| Bausch & Lomb Americas INC. | $75.63 | 2023-2025 | Miebo, Xiidra |
| Dompe US, INC. | $53.90 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $37.59 | 2024-2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $37.37 | 2023 | Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $19.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.